NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









HighLife Medical

HighLife Medical

Private
ParisHealthcare & Life Scienceshttps://www.highlifemedical.com/

Last Round

Series B

Extension

Dec 11, 2020

Total Funding Raised

$50.27M

Company Overview

HighLife Medical is a medical technology company that develops transcatheter mitral valve replacement (TMVR) systems for patients with mitral regurgitation.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

transcatheter mitral valve replacementTMVRmitral regurgitationstructural heartminimally invasive surgerytransseptalinterventional cardiologymedical deviceFDA breakthroughheart valve replacementvalve implantmitral valve repaircardiac surgerystructural heart deviceclinical trial

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

HighLife Medical Comparables

Compare HighLife Medical with similar companies based on industry and business-model similarity.

HighLife Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
4C Medical Technologies, Inc.
87%
Tioga Cardiovascular
86%
InnovHeart
86%

HighLife Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series B ExtensionDec 11, 2020
Series BJan 17, 2019
Series AOct 30, 2017

Key People

Founding team and executive leadership

Steve Backer

Chief Operating Officer

Executive Team

HighLife Medical Investors

Notable investors and investment history

HighLife Medical investors
InvestorRounds
Andera PartnersSeries B
VI PartnersSeries B Extension
U.S. Venture PartnersSeries B
Rives CroissanceSeries A
Sofinnova PartnersSeries B, Series A
SectoralSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 30, 2017

    $14.3M round led by Sofinnova Partners.

HighLife Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

HighLife Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about HighLife Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersParis
Employee Range84
Year Founded2010
Last FundingDec 11, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.